The following bacterial strains were used in this study: Escherichia coli Top10 (Invitrogen, Carlsbad, CA, USA), DH5α (laboratory stock), M. smegmatis mc2155 (laboratory stock), and M. tuberculosis H37Rv (laboratory stock). E. coli strains were grown at 37 °C in Luria-Bertani (LB) broth or on LB agar plates. Mycobacterial strains were grown at 37 °C in Middlebrook 7H9 broth (Difco, Franklin Lakes, NJ, USA) in 150 ml roller bottles with slow rotation (3 rpm), in 10 ml screw-cap tubes without agitation, or Middlebrook 7H10 agar plates (Difco) supplemented with 0.2% glycerol and 0.05% Tween-80. For growth of M. tuberculosis, the medium was supplemented with 10% albumin-dextrose-sodium chloride complex (ADN)14. When needed, antibiotics (Sigma) were added to the media at the following concentrations: streptomycin (Sm) 20 µg ml−1, kanamycin (Km) 50 µg ml−1 (E. coli) or 20 µg ml−1 (M. smegmatis and M. tuberculosis), hygromycin (Hyg) 150 µg ml−1 (E. coli) or 50 µg ml−1 (M. smegmatis and M. tuberculosis), anhydrotetracycline (ATc) 50 ng ml−1 (M. smegmatis) or 500 ng ml−1 (M. tuberculosis). Preparation of electrocompetent cells for electroporation and preparation of mycobacterial genomic DNA were performed as previously described15. M. tuberculosis strains were handled and cultivated in a Biosafety Level 3 Laboratory (BLS3).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.